id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0009-0004,FDA,FDA-1999-D-0009,"Draft Guidance for Industry Disclosure of Materials Provided to Advisory Committees in Connection with Open Advisory Committee Meetings Convened by the Center for Drug Evaluation and Research Beginning on January 1, 2000",Other,Guidance,2014-07-16T04:00:00Z,2014,7,2014-07-16T04:00:00Z,,2014-07-16T14:09:59Z,,0,0,09000064804a59cf
FDA-1999-D-0009-0003,FDA,FDA-1999-D-0009,"Guidance for Industry Disclosure of Materials Provided to Advisory Committees in Connection with Open Advisory Committee Meetings Convened by the Center for Drug Evaluation and Research Beginning on January 1, 2000",Other,Guidance,2014-07-16T04:00:00Z,2014,7,2014-07-16T04:00:00Z,,2014-07-16T14:09:49Z,,0,0,09000064804a59ce
FDA-1999-D-0009-0002,FDA,FDA-1999-D-0009,"Draft Guidance for Industry on Disclosing Information Provided to Advisory Committees in Connection With Open Advisory Committee Meetings Related to the Testing or Approval of New Drugs and Convened by the Center for Drug Evaluation and Research, Beginning on January 1, 2000; Availability",Notice,Notice of Availability,1999-12-23T05:00:00Z,1999,12,1999-12-23T05:00:00Z,2000-02-23T04:59:59Z,2014-07-16T13:42:06Z,,0,0,09000064804a59d0
FDA-1999-D-0009-0001,FDA,FDA-1999-D-0009,"Guidance for Industry on the Disclosure of Materials Provided to Advisory
Committees in Connection with Open Advisory Committee Meetings Convened by the Center for Drug Evaluation and Research Beginning on January 1, 2000; Availability",Notice,Notice of Availability,1999-12-02T05:00:00Z,1999,12,1999-12-02T05:00:00Z,2000-02-29T04:59:59Z,2014-07-17T01:05:09Z,,0,0,09000064804a59ca